# Rejuve.AI and FLT fuse AI insights with science-backed supplements for measurable healthspan

> Rejuve.AI + FLT link AI insights with evidence-led supplements to make healthspan gains measurable. Less promise, more proof: match people to interventions, then track results.

- Type: AI news
- Page: https://completeaitraining.com/news/rejuveai-and-flt-fuse-ai-insights-with-science-backed/
- Published: 2025-10-18
- Updated: 2025-10-18
- Author: Jeroen Erne
- Jobs: Science and research
- Reading time: 3 min

### Rejuve.AI partners with FLT to advance personalized longevity

Published: October 17, 2025 \| Updated: October 17, 2025

The longevity gap isn't science-it's translation. Rejuve.AI and FLT are linking AI-driven insights with evidence-led supplementation to make healthspan gains measurable, not theoretical.

#### Why this matters for researchers

FLT is built on nearly a decade of literature tracking in aging science. Its formulations are evidence-led, manufactured in the US under GMP, and tied to peer-reviewed references for transparency.

Rejuve.AI focuses on individualized analytics and N-of-1 experimentation, combining self-reported outcomes, wearable data and biomarkers. The partnership tests a practical model: match interventions to people, then close the loop with measurement at scale.

This is an attempt to reduce claims without data. Interventions are linked to hypotheses, outcomes and feedback.

#### From data to decisions

FLT's product line targets functional goals: Cognition (clarity), Muscle (strength and recovery), and Longevity (cellular resilience and metabolic support). Ingredients include ErgoActive (ergothioneine), L-theanine, PeptiStrong, creatine, Niagen (nicotinamide riboside), spermidine and fisetin-compounds with clinical literature in energy metabolism, neuroprotection and cellular maintenance.

- Cognition: working memory, processing speed, reaction time; tests such as Symbol Digit Modalities or n-back.
- Muscle: grip strength, vertical jump, isometric mid-thigh pull; recovery via HRV and DOMS scores.
- Longevity: resting HRV, VO2max estimate, fasting insulin/HOMA-IR, lipid subfractions, hs-CRP, epigenetic clocks where applicable.
- Mechanistic proxies: NAD+ adjacents for NR; autophagy-related markers for spermidine (where feasible in research settings).
- Adherence and tolerability: dosing logs, GI tolerance, sleep disruption, perceived energy.

#### AI as a feedback engine

Rejuve.AI ingests lifestyle inputs, wearable streams and lab markers to generate adaptive recommendations. The community-driven N-of-1 approach fits an area with high heterogeneity of response and practical constraints on RCTs for every stack component. See an overview of N-of-1 methods in clinical care at the [BMJ](https://www.bmj.com/content/357/bmj.j2087?ref=completeaitraining.com).

**"The future of longevity isn't just about discovering new molecules - it's about how individuals respond to them,"** said Dev Heaton, Head of FLT. **"Partnering with Rejuve.AI connects our formulations with real-world data, helping people see how cellular, cognitive and physical performance can evolve over time."**

#### Practical study design notes

- Pre-specify primary and secondary outcomes, effect direction, and time horizons (e.g., 6-12 weeks per phase).
- Use designs that fit daily life: A-B, A-B-A, or alternating sequences with wash-in/wash-out where biologically appropriate.
- Standardize measurement cadence: morning fasting labs; same-time daily cognitive tasks; weekly strength tests.
- Control confounding: stable training volume, sleep targets, caffeine windows, and step counts during phases.
- Quantify adherence objectively (pill counts, smart caps) and subjectively (daily check-ins).
- Report uncertainty: within-person effect sizes, confidence/credible intervals; adjust for multiplicity if testing many endpoints.
- Track adverse events and discontinuations; define stop rules.
- Privacy by design: consent flows, de-identification, and governance for data reuse.

#### What to watch in the data

- Responder analysis: identify characteristics linked to positive, null or negative responses.
- Dose-response and timing: morning vs evening dosing, fed vs fasted state.
- Concordance: do biomarker shifts align with performance and patient-reported outcomes?
- Device and batch effects: wearable firmware changes; supplement lot traceability.
- Generalizability: replicate across demographics, training status and baseline health.

#### Guardrails and limits

Supplements are not drugs; effects tend to be modest and context-dependent. Many endpoints are noisy, and publication bias is common. Maintain restraint, publish nulls and prioritize clinically meaningful effects over small statistical wins.

For example, creatine has a well-characterized safety and efficacy profile in performance and some cognitive contexts; see the NIH ODS fact sheet for a concise overview: [Creatine - Health Professional](https://ods.od.nih.gov/factsheets/Creatine-HealthProfessional/?ref=completeaitraining.com).

#### Why this collaboration is interesting for the field

It moves supplementation from static "stacks" to living protocols informed by data. Less promise, more proof: open references, measurable endpoints and iteration based on individual response.

If executed with rigor-pre-registration, transparent methods, and sharable aggregate outcomes-this model can help align consumer practice with standards familiar to clinical and translational researchers.

#### If you're building your own protocol

- Define one clear goal (e.g., improve working memory or lower fasting insulin).
- Select 1-2 interventions; avoid stacking changes that mask signal.
- Run a structured N-of-1 for 8-12 weeks with a stable routine and fixed measurement windows.
- Track 3-5 high-signal metrics (one primary), plus adherence and adverse events.
- Review quarterly; keep what shows a meaningful effect, retire what doesn't.

For researchers and teams upgrading AI skills for biomarker and wearable analytics, curated training can help operationalize these workflows: [AI courses by job role](https://completeaitraining.com/courses-by-job/).

Bottom line: FLT supplies evidence-led interventions; Rejuve.AI supplies the measurement and adaptation layer. If the feedback loop holds, consumer longevity gets more accountable-and measurably useful.

---

This is the Markdown form of https://completeaitraining.com/news/rejuveai-and-flt-fuse-ai-insights-with-science-backed/. The whole site is mapped at https://completeaitraining.com/llms.txt.
